Merlo A - Search Results

1

Selective cell cycle arrest in glioblastoma cell lines by quantum molecular resonance alone or in combination with temozolomide.

Catanzaro D, Milani G, Bozza A, Bernardi M, Chieregato K, Menarin M, Merlo A, Celli P, Belli R, Peroni D, Pozzato A, Pozzato G, Raneri FA, Volpin L, Ruggeri M, Astori G. Catanzaro D, et al. Among authors: merlo a. Br J Cancer. 2022 Sep;127(5):824-835. doi: 10.1038/s41416-022-01865-9. Epub 2022 Jun 17. Br J Cancer. 2022. PMID: 35715634 Free PMC article.

2

Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry ice.

Astori G, Bernardi M, Bozza A, Catanzaro D, Chieregato K, Merlo A, Santimaria M, Barbazza R, Amodeo G, Ciccocioppo R, Elice F, Ruggeri M. Astori G, et al. Among authors: merlo a. J Transl Med. 2020 Nov 30;18(1):451. doi: 10.1186/s12967-020-02625-0. J Transl Med. 2020. PMID: 33256746 Free PMC article.

3

Reprogramming T lymphocytes for melanoma adoptive immunotherapy by T-cell receptor gene transfer with lentiviral vectors.

Bobisse S, Rondina M, Merlo A, Tisato V, Mandruzzato S, Amendola M, Naldini L, Willemsen RA, Debets R, Zanovello P, Rosato A. Bobisse S, et al. Among authors: merlo a. Cancer Res. 2009 Dec 15;69(24):9385-94. doi: 10.1158/0008-5472.CAN-09-0494. Cancer Res. 2009. PMID: 19996290

4

Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer.

Turrini R, Merlo A, Dolcetti R, Zanovello P, Rosato A. Turrini R, et al. Among authors: merlo a. Cancer Immunol Immunother. 2011 Nov;60(11):1639-45. doi: 10.1007/s00262-011-1086-3. Epub 2011 Aug 11. Cancer Immunol Immunother. 2011. PMID: 21833593 Free PMC article.

5

Survivin expression and prognostic significance in pediatric malignant peripheral nerve sheath tumors (MPNST).

Alaggio R, Turrini R, Boldrin D, Merlo A, Gambini C, Ferrari A, Dall'igna P, Coffin CM, Martines A, Bonaldi L, De Salvo GL, Zanovello P, Rosato A. Alaggio R, et al. Among authors: merlo a. PLoS One. 2013 Nov 26;8(11):e80456. doi: 10.1371/journal.pone.0080456. eCollection 2013. PLoS One. 2013. PMID: 24303016 Free PMC article.

6

Adoptive cell therapy against EBV-related malignancies: a survey of clinical results.

Merlo A, Turrini R, Dolcetti R, Zanovello P, Amadori A, Rosato A. Merlo A, et al. Expert Opin Biol Ther. 2008 Sep;8(9):1265-94. doi: 10.1517/14712598.8.9.1265. Expert Opin Biol Ther. 2008. PMID: 18694349 Review.

7

Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors.

Merlo A, Turrini R, Bobisse S, Zamarchi R, Alaggio R, Dolcetti R, Mautner J, Zanovello P, Amadori A, Rosato A. Merlo A, et al. J Immunol. 2010 May 15;184(10):5895-902. doi: 10.4049/jimmunol.0902850. Epub 2010 Apr 12. J Immunol. 2010. PMID: 20385879

8

Impact of γ-chain cytokines on EBV-specific T cell cultures.

Merlo A, Turrini R, Trento C, Zanovello P, Dolcetti R, Rosato A. Merlo A, et al. J Transl Med. 2010 Nov 22;8:121. doi: 10.1186/1479-5876-8-121. J Transl Med. 2010. PMID: 21092174 Free PMC article.

9

Immunotherapy for EBV-associated malignancies.

Merlo A, Turrini R, Dolcetti R, Zanovello P, Rosato A. Merlo A, et al. Int J Hematol. 2011 Mar;93(3):281-293. doi: 10.1007/s12185-011-0782-2. Epub 2011 Feb 19. Int J Hematol. 2011. PMID: 21336546

10

Functional avidity-driven activation-induced cell death shapes CTL immunodominance.

Dalla Santa S, Merlo A, Bobisse S, Ronconi E, Boldrin D, Milan G, Barbieri V, Marin O, Facchinetti A, Biasi G, Dolcetti R, Zanovello P, Rosato A. Dalla Santa S, et al. Among authors: merlo a. J Immunol. 2014 Nov 1;193(9):4704-11. doi: 10.4049/jimmunol.1303203. Epub 2014 Sep 22. J Immunol. 2014. PMID: 25246498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

418 results

Search Page